APOE and Alzheimer disease: Likewise, although cross-sectional studies across the AD-spectrum have found higher WMH burden in APOE-ɛ2 carriers relative to ɛ3/ɛ3 homozygotes,40 the impact of the APOE-ɛ2 allele on longitudinal changes in WMH burden in cognitively normal individuals remains unclear.